Avantor, Inc. (NYSE:AVTR) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Avantor, Inc. (NYSE:AVTR) has been assigned a consensus rating of “Moderate Buy” from the thirteen research firms that are covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $27.38.

Several brokerages have recently weighed in on AVTR. UBS Group restated a “neutral” rating and set a $25.00 price target (down from $29.00) on shares of Avantor in a report on Friday, January 17th. Wells Fargo & Company decreased their target price on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a report on Monday, October 28th. Robert W. Baird cut their price target on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a report on Monday, October 28th. Barclays decreased their price objective on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a report on Friday, October 25th. Finally, Raymond James cut their target price on Avantor from $29.00 to $26.00 and set an “outperform” rating on the stock in a research note on Tuesday, January 21st.

Avantor Stock Up 0.9 %

AVTR stock opened at $22.07 on Monday. The business has a 50 day moving average of $21.50 and a 200 day moving average of $23.41. The firm has a market cap of $15.02 billion, a PE ratio of 47.97, a price-to-earnings-growth ratio of 3.53 and a beta of 1.28. Avantor has a twelve month low of $19.59 and a twelve month high of $28.00. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84.

Hedge Funds Weigh In On Avantor

Several institutional investors have recently made changes to their positions in the business. MassMutual Private Wealth & Trust FSB increased its holdings in Avantor by 99.5% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock valued at $26,000 after buying an additional 625 shares during the last quarter. UMB Bank n.a. bought a new stake in shares of Avantor during the 3rd quarter valued at $49,000. Nisa Investment Advisors LLC increased its stake in shares of Avantor by 69.6% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock worth $53,000 after purchasing an additional 835 shares in the last quarter. GAMMA Investing LLC raised its holdings in Avantor by 89.9% in the 3rd quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock worth $70,000 after purchasing an additional 1,285 shares during the period. Finally, Livforsakringsbolaget Skandia Omsesidigt raised its holdings in Avantor by 278.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 5,031 shares of the company’s stock worth $130,000 after purchasing an additional 3,700 shares during the period. Institutional investors own 95.08% of the company’s stock.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.